HSBC Commence Coverage on Genus (GNS) – BharataPress
Research analysts at HSBC initiated coverage on shares of Genus (LON:GNS) in a research note issued to investors on Tuesday, February 12th. Finally, Kepler Capital Markets upgraded Genus to a “buy” rating and upped their target price for the company from GBX 2,475 ($32.34) to GBX 2,630 ($34.37) in a research note on Thursday, December 6th. Genus has a 12 month low of GBX 1,652 ($21.59) and a 12 month high of GBX 2,597 ($33.93). Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia.